Evidence for association of multi-exon skipping events with tumors

Abstract

Alternative splicing (AS) has been shown to be frequently present in human tumors. Specifically, it has been observed in some experimental studies that multi-exon skipping (MES) events often appear in tumorous tissues. Prompted by this observation, we conducted a genome-wide analysis of MES events to investigate their association with tumors. The results show that MES events are more likely associated with tumors than single-exon skipping (SES) and the degree of association increases with the number of skipped exons. Furthermore, MES events are found to be less conserved than their SES counterparts, which provides additional evidence for our results because disease-associated AS events should be eliminated during evolution. Interestingly, these differences still existed even after comparison of MES and SES events with similar-length skipped regions. These results demonstrate that MES events may be associated with tumors and suggest that MES isoforms might be useful in cancer diagnosis.

References

1. Black D L Mechanismsof alternative pre-messenger RNA splicingAnnual Review of Biochemistry 2003 72291336. doi:10.1146/annurev.biochem.72.121801.161720
2. Krawczak M Reiss J Cooper D N The mutational spectrum of single base-pair substitutionsin mRNA splice junctions of human genes: causes and consequencesHuman Genetics 1992 90(1–2)4154
3. Wang G S Cooper T A Splicing in disease: disruptionof the splicing code and the decoding machineryNature Review Genetics 2007 8(10)749761. doi:10.1038/nrg2164
4. Hui L Zhang X Wu X et al.Identification of alternatively spliced mRNA variantsrelated to cancers by genome-wide ESTs alignment Oncogene 2004 23(17)30133023. doi:10.1038/sj.onc.1207362
5. Xu Q Lee C Discovery of novel splice formsand functional analysis of cancer-specific alternative splicing inhuman expressed sequencesNucleic AcidsResearch 2003 31(19)56355643. doi:10.1093/nar/gkg786
6. Wang Z Lo H S Yang H et al.Computational analysis and experimental validationof tumor-associated alternative RNA splicing in human cancerCancer Research 2003 63(3)655657
7. Brinkman B M Splicevariants as cancer biomarkersClinical Biochemistry 2004 37(7)584594. doi:10.1016/j.clinbiochem.2004.05.015
8. Li H R Wang-Rodriguez J Nair T M et al.Two-dimensional transcriptome profiling: identificationof messenger RNA isoform signatures in prostate cancer from archivedparaffin-embedded cancer specimensCancerResearch 2006 66(8)40794088. doi:10.1158/0008‐5472.CAN‐05‐4264
9. Zhang C Li H R Fan J B et al.Profiling alternatively spliced mRNA isoforms forprostate cancer classificationBMC Bioinformatics 2006 7202. doi: 10.1186/1471‐2105‐7‐202
10. Wang Z Zhang X Shen P et al.Identification, cloning, and expression of humanestrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66Biochemical and Biophysical Research Communications 2005 336(4)10231027. doi:10.1016/j.bbrc.2005.08.226
11. Matthews J Almlof T Kietz S et al.Estrogen receptor-alpha regulates SOCS-3 expressionin human breast cancer cellsBiochemicaland Biophysical Research Communications 2005 335(1)168174. doi:10.1016/j.bbrc.2005.07.057
12. Van Dijk M A Hart A A Van Veer L J Differences in estrogen receptor alpha variant messengerRNAs between normal human breast tissue and primary breast carcinomasCancer Research 2000 60(3)530533
13. Cote M Miller A D Liu S L Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymaltransition but causes cellular senescenceBiochemical and Biophysical Research Communications 2007 360(1)219225. doi:10.1016/j.bbrc.2007.06.033
14. Zhou Y Q He C Chen Y Q et al.Altered expression of the RON receptor tyrosinekinase in primary human colorectal adenocarcinomas: generation ofdifferent splicing RON variants and their oncogenic potentialOncogene 2003 22(2)186197. doi:10.1038/sj.onc.1206075
15. Ast G Howdid alternative splicing evolveNature ReviewGenetics 2004 5(10)773782. doi:10.1038/nrg1451
16. Pan Q Shai O Misquitta C et al.Revealing global regulatory features of mammalianalternative splicing using a quantitative microarray platformMolecular Cell 2004 16(6)929941. doi:10.1016/j.molcel.2004.12.004
17. Sorek R Shamir R Ast G How prevalent is functional alternative splicing in thehuman genomeTrends in Genetics 2004 20(2)6871. doi:10.1016/j.tig.2003.12.004
18. Xing Y Lee C J Protein modularity of alternativelyspliced exons is associated with tissue-specific regulation of alternativesplicingPLoS Genetics 2005 1(3)e34. doi: 10.1371/journal.pgen.0010034
19. Thanaraj T A Clark F Muilu J Conservation of human alternative splice events in mouseNucleic Acids Research 2003 31(10)25442552. doi:10.1093/nar/gkg355
20. Boguski M S Lowe T M Tolstoshev C M dbEST–database for “expressed sequence tags”Nature Genetics 1993 4(4)332333. doi:10.1038/ng0893‐332
21. Castillo-Davis C I Mekhedov S L Hartl D L et al.Selection for short introns in highly expressedgenesNature Genetics 2002 31(4)415418
22. Wang P Yan B Guo J T et al.Structural genomics analysis of alternative splicingand application to isoform structure modelingProceedings of the National Academy of Sciences of the United Statesof America 2005 102(52)1892018925. doi:10.1073/pnas.0506770102
23. la Cour J M Mollerup J Berchtold M W ALG-2 oscillates in sub-cellular localization, uni-temporallywith calcium oscillationsBiochemical andBiophysical Research Communications 2007 353(4)10631067. doi:10.1016/j.bbrc.2006.12.143
24. Shibata H Suzuki H Yoshida H et al.ALG-2 directly binds Sec31A and localizes at endoplasmicreticulum exit sites in a Ca²⁺-dependentmannerBiochemical and Biophysical ResearchCommunications 2007 353(3)756763. doi:10.1016/j.bbrc.2006.12.101
25. Tarabykina S Mollerup J Winding P et al.ALG-2, a multifunctional calcium binding proteinFrontiers in Bioscience 2004 918171832. doi:10.2741/1358
26. Zhang C Krainer A R Zhang M Q Evolutionary impact of limited splicing fidelity in mammaliangenesTrends in Genetics 2007 23(10)484488. doi:10.1016/j.tig.2007.08.001
27. Tanko Q Franklin B Lynch H et al.A hMLH1 genomic mutation and associated novel mRNAdefects in a hereditary non-polyposis colorectal cancer familyMutation Research 2002 503(1–2)3742